(73) Assignee: Egalet Ltd., London (GB)(*) Notice: Subject to any disclaimer, the term of this
patent is extended or adjusted under 35 USC 154 (b) by 2251 days.(21) Appl. No …

Layered pharmaceutical composition Suitable for oral use in the treatment of diseases
where absorption takes place over a large part of the gastrointestinal tract. The composition …

The present invention relates to pharmaceutical composi tions, which provide controlled
release of a drug. The com positions are Suitable for continuous administration as they …

Controlled release formulations and methods for preparing controlled release formulations
for delivery of active drug substances are described herein. The formulations described …

Current polymeric research has explored various applications in drug delivery and its
related biomedical applications. Natural polymers especially those are derived from plant …

Abuse resistant polyglycol-based pharmaceutical composi tions are disclosed. The
composition contains one or more polyglycols and one or more active Substances and it is …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
48703579&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

The present invention relates to immediate release pharma ceutical compositions for oral
administration that are resis tant to abuse by intake of alcohol. In particular, this disclosure …

US8603526B2 - Pharmaceutical compositions resistant to abuse - Google Patents
US8603526B2 - Pharmaceutical compositions resistant to abuse - Google Patents …

US10800779B2 - Heterocyclic compounds as LSD1 inhibitors - Google Patents
US10800779B2 - Heterocyclic compounds as LSD1 inhibitors - Google Patents …